Ashton Thomas Securities LLC Has $335,000 Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Ashton Thomas Securities LLC raised its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 1,097.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 563 shares of the biotechnology company’s stock after acquiring an additional 516 shares during the quarter. Ashton Thomas Securities LLC’s holdings in Axon Enterprise were worth $335,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Public Sector Pension Investment Board lifted its stake in Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the last quarter. Soros Capital Management LLC acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $630,000. Friedenthal Financial boosted its stake in shares of Axon Enterprise by 961.7% during the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after acquiring an additional 1,231 shares during the period. Principal Financial Group Inc. increased its holdings in shares of Axon Enterprise by 33.1% during the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after acquiring an additional 33,869 shares during the last quarter. Finally, XTX Topco Ltd lifted its holdings in Axon Enterprise by 20.6% during the 3rd quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock valued at $2,258,000 after purchasing an additional 964 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the subject of several research reports. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Needham & Company LLC reissued a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, February 26th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $577.18 on Wednesday. The firm’s 50 day simple moving average is $591.92 and its 200 day simple moving average is $546.67. The firm has a market capitalization of $44.23 billion, a price-to-earnings ratio of 149.14, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Insiders Place Their Bets

In other news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.